Allievex
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
PO Box 1056, Marblehead, Massachusetts, ...Phone Number
(617) 642-8677Website
www.allievex.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Allievex
Allievex is dedicated to developing first- and best-in-class therapies for children suffering from rare and severe neurological diseases. The company focuses on enzyme replacement therapy, specifically through its lead drug, tralesinidase alfa, which shows promising results for patients with Sanfilippo syndrome type B. With a team experienced in therapeutic development for neurological conditions, Allievex aims to unlock effective treatments for various rare pediatric neurological diseases. Their mission emphasizes the importance of innovative solutions to improve the lives of affected children and their families.Explore more
Allievex Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Allievex your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Allievex, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Allievex
Product Launch: Get notified when Allievex launches new products
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Allievex recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Allievex has recently received funding, and reach out quickly before it becomes old news!
Check out if Allievex is spiking on competitors!
Click to see if Allievex had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Allievex has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Allievex
Compare insights from companies similar to Allievex, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
<$5M
11-50
Private
<$5M
2005
CL
Cynthia LevinthalPrincipal Consultant. Neural Stem Cell Therapies. Clinical Trials
Company Profile Activity
Activity Insights
Allievex is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Allievex is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Allievex.
Allievex Tech Stack
A closer look at the technologies used by Allievex
Allievex News & Media
Allievex Completes Series A Financing Led by Pappas Capital and Novo Holdings
MARBLEHEAD, Mass., Oct. 23, 2019 /PRNewswire/ -- Allievex Corporation ("Allievex"), a clinical-stage biotechnology company founded by Pappas Capital, today announced the completion of a Series A financing co-led by Novo Holdings and Pappas Capital. Allievex has also appointed Kyle...Allievex Completes Series A Financing
MARBLEHEAD, MA, Clinical-stage biotechnology company founded by Pappas Capital, today announced the completion of a Series A financing.Allievex Completes Series A Financing Led by Pappas Capital and Novo Holdings
Venture capital news. Updated daily. VC deal news, fund news, transition news, industry news.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Allievex
Sign Up For FreeTo access detailed company insights
Allievex is dedicated to developing first- and best-in-class therapies for children suffering from rare and severe neurological diseases. The company focuses on enzyme replacement therapy, specifically through its lead drug, tralesinidase alfa, which shows promising results for patients with Sanfilippo syndrome type B. With a team experienced in th... Read More
